Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 StudyCatherine Thiéblemont, Franck Morschhauser, Alessandra Tucci et al.|Blood|2022Cited by 16